December 12, 2014
Catching Up with the RARE Daily: Yondelis, Novartis & KCNQ2
Read More
December 10, 2014
Janssen Reveals New Drug in the Pipeline for Treatment of Advanced Soft Tissue Sarcoma
Read More
October 24, 2014
IMBRUVICA® (ibrutinib) Supplemental New Drug Application Submitted to the U.S. FDA for Waldenstrom’s macroglobulinemia
Read More
June 30, 2014
SYLVANT™ (siltuximab) Receives FDA Approval to Treat Multicentric Castleman’s Disease (MCD)
Read More
X